Fast track — Research LettersResults of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
References (5)
- et al.
American Society of Clinical Oncology Technology on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone-receptor-positive breast cancer: status report 2004
J Clin Oncol
(2004) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
Lancet
(2002)
There are more references available in the full text version of this article.
Cited by (0)
Members listed at http://image.thelancet.com/extras/04let11120webappendix.pdf
Copyright © 2005 Elsevier Ltd. All rights reserved.